RELATIONSHIP BETWEEN HISTO-ENDOSCOPIC MUCOSAL HEALING AND BASELINE CHARACTERISTICS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS RECEIVING FILGOTINIB IN THE PHASE 2B/3 SELECTION STUDY

Laurent Peyrin-Biroulet  ¹     Edward V. Loftus Jr  ²     Toshifumi Hibi  ³     Christine Birchwood  ⁴     Chohee Yun  ⁴     Sally Zhao  ⁴     Xiaopeng Liu  ⁴     Gerhard Rogler  ⁵     Silvio Danese  ⁶     Jean-Frédéric Colombel  ⁷     Brian G. Feagan  ^8    
1 University Hospital of Nancy, Vandoeuvre-lès-Nancy, France
² Mayo Clinic College of Medicine and Science, Rochester, MN, United States
³ Kitasato Institute Hospital, Kitasato University, Tokyo, Japan
⁴ Gilead Sciences, Inc., Foster City, CA, United States
⁵ University Hospital of Zurich, Zürich, Switzerland
⁶ Humanitas Clinical and Research Center, Milan, Italy
⁷ Icahn School of Medicine at Mount Sinai, New York City, NY, United States
⁸ Western University, London, ON, Canada

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)